TY - JOUR
T1 - Modification of Interpersonal Psychotherapy with Depressed Adolescents (IPT-A)
T2 - Phase I and II Studies
AU - MUFSON, LAURA
AU - MOREAU, DONNA
AU - WEISSMAN, MYRNA M.
AU - WICKRAMARATNE, PRIYA
AU - MARTIN, JACQUELINE
AU - SAMOILOV, ANNA
N1 - Funding Information:
This research was supported by a NARSAD Young Investigator Award to Dr. Mufion. The authors thank Patricia Bellucci, M.A., ftr her assistance in data analysis.
PY - 1994
Y1 - 1994
N2 - To test the acceptability and efficacy of interpersonal psychotherapy for depressed adolescents (IPT-A). In phase I, therapeutic methods were explored and refined in a small sample of depressed adolescents (n = 5). in phase II, 14 depressed adolescents entered a 12-week open clinical trial of IPT-A; after independent evaluation. Subjects were assessed using a semistructured diagnostic interview, self-report, and clinician-administered instruments, at six time points: evaluation week, and weeks 0, 2, 4, 8, and 12. In phase I, treatment was modified to meet the needs of an adolescent population and was standardized in a treatment manual. The results of phase II indicated a significant decrease in adolescents' depressive symptomatology and symptoms of psychological and physical distress, as well as a significant improvement in functioning over the course of treatment. At termination, none of the subjects met DSM-III-R criteria for any depressive disorder. IPT-A appears to be a promising therapy for depressed adolescents. However, because of the limitations of the current study, a larger randomized controlled clinical trial is still needed to test its efficacy.
AB - To test the acceptability and efficacy of interpersonal psychotherapy for depressed adolescents (IPT-A). In phase I, therapeutic methods were explored and refined in a small sample of depressed adolescents (n = 5). in phase II, 14 depressed adolescents entered a 12-week open clinical trial of IPT-A; after independent evaluation. Subjects were assessed using a semistructured diagnostic interview, self-report, and clinician-administered instruments, at six time points: evaluation week, and weeks 0, 2, 4, 8, and 12. In phase I, treatment was modified to meet the needs of an adolescent population and was standardized in a treatment manual. The results of phase II indicated a significant decrease in adolescents' depressive symptomatology and symptoms of psychological and physical distress, as well as a significant improvement in functioning over the course of treatment. At termination, none of the subjects met DSM-III-R criteria for any depressive disorder. IPT-A appears to be a promising therapy for depressed adolescents. However, because of the limitations of the current study, a larger randomized controlled clinical trial is still needed to test its efficacy.
UR - http://www.scopus.com/inward/record.url?scp=0028321516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028321516&partnerID=8YFLogxK
U2 - 10.1097/00004583-199406000-00011
DO - 10.1097/00004583-199406000-00011
M3 - Article
C2 - 8056733
AN - SCOPUS:0028321516
SN - 0890-8567
VL - 33
SP - 695
EP - 705
JO - Journal of the American Academy of Child and Adolescent Psychiatry
JF - Journal of the American Academy of Child and Adolescent Psychiatry
IS - 5
ER -